Home › Acute Myeloid Leukemia › Connecticut › Bridgeport
Pag-aaral pangklinika para sa Acute Myeloid Leukemia sa Bridgeport, CT
Isang pag-aaral para sa Acute Myeloid Leukemia ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Bridgeport. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Nagre-recruitPhase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Nagre-recruitPhase 2
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Nagre-recruitPhase 3
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Nagre-recruitPhase 1/2
- Stony Brook University Medical Center, Stony Brook · 18 mi ang layo
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Nagre-recruitPhase 1
- Stony Brook Cancer Center, Stony Brook · 18 mi ang layo
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
Nagre-recruitObservasyonal na pag-aaral
- Stony Brook Cancer Center, Stony Brook · 18 mi ang layo
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Nagre-recruitObservasyonal na pag-aaral
- Stony Brook University Hospital, Stony Brook · 18 mi ang layo
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Nagre-recruitPhase 1
- Stony Brook University Hospital, Stony Brook · 18 mi ang layo
Pag-aaral para sa Acute Myeloid Leukemia sa ibang lungsod
- Houston, TX85 pag-aaral
- New York City, NY51 pag-aaral
- Boston, MA44 pag-aaral
- Seattle, WA41 pag-aaral
- Baldwin Park, CA40 pag-aaral
- Columbus, OH35 pag-aaral
- Philadelphia, PA34 pag-aaral
- Durham, NC33 pag-aaral
- Atlanta, GA31 pag-aaral
- Tampa, FL29 pag-aaral
- Chicago, IL26 pag-aaral
- Portland, OR25 pag-aaral
Iba pang pag-aaral sa Bridgeport
- Kanser sa Suso21 pag-aaral
- Non-Small Cell Lung Cancer14 pag-aaral
- Kanser sa Baga13 pag-aaral
- Sakit sa Puso at Ugat ng Dugo9 pag-aaral
- Kanser (lahat ng uri)8 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg8 pag-aaral
- Metastatic Cancer7 pag-aaral
- Pagkabigo ng Puso7 pag-aaral
- Brain Aneurysm6 pag-aaral
- Multiple Myeloma6 pag-aaral
- Kanser sa Prostate6 pag-aaral
- Kanser sa Ovary5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.